Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches
- 1 January 2005
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 22 (1) , 103-112
- https://doi.org/10.1007/s11095-004-9015-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Prediction of Pharmacokinetics Prior to In Vivo Studies. II. Generic Physiologically Based Pharmacokinetic Models of Drug DispositionJournal of Pharmaceutical Sciences, 2002
- Prediction of Hepatic Metabolic ClearanceClinical Pharmacokinetics, 2001
- Prediction of in vivo drug metabolism in the human liver from in vitro metabolism dataPharmacology & Therapeutics, 1997
- Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeineXenobiotica, 1995
- Interspecies Metabolism and Pharmacokinetic Scaling of Theophylline DispositionDrug Metabolism Reviews, 1990
- A Carrier–Protein Receptor Is Not A Prerequisite for Avid Hepatic Elimination of Highly Bound Compounds: A Study of Propranolol Elimination by the Isolated Perfused Rat LiverHepatology, 1985
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Animal scale-upJournal of Pharmacokinetics and Biopharmaceutics, 1973